This disruption may explain why some patients present with hollowing, sagging, and an overall dullness that feels out of proportion to their weight loss alone
Microbiota-derived SCFA can induce the release of incretins, including peptide tyrosine-tyrosine (PYY) and GLP-1, which modulate hunger and glucose metabolism 59
If youre pregnant or breastfeeding Regulatory bodies, including the MHRA, advise that GLP-1 medications should not be used during pregnancy or while breastfeeding
You should contact your GP or NHS 111 if you experience severe, persistent vomiting or diarrhoea that prevents you from keeping down fluids, as this can lead to dehydration and electrolyte imbalance
The administration of VB significantly decreased the phosphorylation levels of IKK and IKK, IB, and NF-B-p65
Medical weight loss works best when the plan protects muscle and supports long-term habits